Analyze Diet
Frontiers in veterinary science2019; 6; 64; doi: 10.3389/fvets.2019.00064

The Effect of Autologous Protein Solution on the Inflammatory Cascade in Stimulated Equine Chondrocytes.

Abstract: Cartilage injury occurs commonly in equine athletes, often precipitating posttraumatic osteoarthritis (PTOA). Orthobiologics such as autologous conditioned serum (ACS) and autologous protein solution (APS) may be useful in decreasing posttraumatic inflammation, thereby preventing PTOA. The objective of this study was to quantify cytokine concentrations in ACS and APS and evaluate the protective effects of ACS and APS on inflamed chondrocytes cultured . We hypothesized that the combination of platelet-derived growth factors (PDGF) and anti-inflammatory cytokines present in APS would be superior in decreasing the inflammatory and catabolic cascade in inflamed chondrocytes when compared to ACS in which platelets are excluded from the preparation. Chondrocytes were isolated from the cartilage of femoral trochlear ridges of 6 horses and cultured in 12-well transwell plates. Treatment groups included: (1) control, (2) APS (Pro-Stride; Owl Manor), and (3) ACS (IRAP II; Arthrex). Each group was unstimulated or stimulated with IL-1β and TNF-α for 48 h. The concentration of IL-1β, IL-6, TNF-α, MMP-3, MMP-13, and IL-10 was quantified using a fluorescent bead-based multiplex assay. IL-1Ra concentration was quantified using ELISA. APS and ACS both had significantly increased concentrations of IL-1Ra without a concurrent increase in IL-1β concentration. After 48 h of culture, media from chondrocytes treated with APS contained significantly increased concentrations of IL-1Ra and IL-10. APS-treated cultures had increased concentrations of IL-6. Overall, APS effectively concentrated IL-1Ra without an incubation period and media from APS-treated chondrocytes had increased concentrations of chondroprotective (IL-1Ra and IL-10) and modulatory (IL-6) cytokines, which may be beneficial in the treatment of inflammatory conditions such as PTOA.
Publication Date: 2019-03-06 PubMed ID: 30895181PubMed Central: PMC6414419DOI: 10.3389/fvets.2019.00064Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper presents a study on the impact of using autologous protein solution (APS) and autologous conditioned serum (ACS) on induced inflammation in horse cartilage cells. The study concludes that APS concentrated protective cytokines without needing incubation and led to increased levels of chondroprotective and modulatory cytokines, which could be beneficial in treating inflammatory conditions like posttraumatic osteoarthritis.

Objective of the Research

  • The research aimed to quantify cytokine concentrations in APS and ACS and evaluate their protective effects on inflamed chondrocytes (cartilage cells).
  • The researchers hypothesized that the combination of platelet-derived growth factors (PDGF) and anti-inflammatory cytokines present in APS would be superior to the ACS in alleviating inflammation in chondrocytes.

The Study Procedure

  • The study was conducted by isolating chondrocytes from the cartilage of femoral trochlear ridges of 6 horses and cultivating them in 12-well transwell plates.
  • The treatment groups included a control group, a group treated with APS, and a group treated with ACS.
  • The researchers either left the groups alone or stimulated them with the pro-inflammatory cytokines IL-1β and TNF-α for 48 hours.
  • After the treatment period, the researchers quantified the concentrations of several cytokines using a fluorescent bead-based multiplex assay and an ELISA.

Key Findings

  • Both APS and ACS showed significantly increased concentrations of the anti-inflammatory cytokine IL-1Ra, without an increase in the inflammatory cytokine IL-1β concentration.
  • The media from chondrocytes treated with APS showed significantly increased concentrations of IL-1Ra and another anti-inflammatory cytokine IL-10.
  • APS-treated cultures demonstrated increased concentrations of the modulatory cytokine IL-6.

Conclusion of the Research

  • APS can effectively concentrate the anti-inflammatory cytokine IL-1Ra without an incubation period, increasing its potential utility in treating inflammatory conditions.
  • The media from APS-treated chondrocytes had higher concentrations of chondroprotective (IL-1Ra and IL-10) and modulatory (IL-6) cytokines, which could be beneficial for treating posttraumatic osteoarthritis.

Cite This Article

APA
Linardi RL, Dodson ME, Moss KL, King WJ, Ortved KF. (2019). The Effect of Autologous Protein Solution on the Inflammatory Cascade in Stimulated Equine Chondrocytes. Front Vet Sci, 6, 64. https://doi.org/10.3389/fvets.2019.00064

Publication

ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 6
Pages: 64
PII: 64

Researcher Affiliations

Linardi, Renata L
  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania, Kennett Square, PA, United States.
Dodson, Michael E
  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania, Kennett Square, PA, United States.
Moss, Kaitlyn L
  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania, Kennett Square, PA, United States.
King, William J
  • Owl Manor Veterinary Inc., Warsaw, IN, United States.
Ortved, Kyla F
  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania, Kennett Square, PA, United States.

Grant Funding

  • T35 OD010919 / NIH HHS

References

This article includes 37 references
  1. Mankin HJ. The response of articular cartilage to mechanical injury.. J Bone Joint Surg Am 1982 Mar;64(3):460-6.
  2. Strauss EJ, Goodrich LR, Chen CT, Hidaka C, Nixon AJ. Biochemical and biomechanical properties of lesion and adjacent articular cartilage after chondral defect repair in an equine model.. Am J Sports Med 2005 Nov;33(11):1647-53.
    doi: 10.1177/0363546505275487pubmed: 16093540google scholar: lookup
  3. Olson SA, Horne P, Furman B, Huebner J, Al-Rashid M, Kraus VB, Guilak F. The role of cytokines in posttraumatic arthritis.. J Am Acad Orthop Surg 2014 Jan;22(1):29-37.
    doi: 10.5435/JAAOS-22-01-29pubmed: 24382877google scholar: lookup
  4. Oke S, Mcilwraith C. Review of the economic impact of osteoarthritis and oral joint-health supplements in horses. Am Asocciation Equine Pract (2010) 56:12–6.
  5. Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors.. Arthroscopy 2012 Mar;28(3):429-39.
    doi: 10.1016/j.arthro.2011.10.018pubmed: 22284405google scholar: lookup
  6. Evans CH, Chevalier X, Wehling P. Autologous Conditioned Serum.. Phys Med Rehabil Clin N Am 2016 Nov;27(4):893-908.
    doi: 10.1016/j.pmr.2016.06.003pubmed: 27788906google scholar: lookup
  7. Frisbie DD, Kawcak CE, Werpy NM, Park RD, McIlwraith CW. Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis.. Am J Vet Res 2007 Mar;68(3):290-6.
    doi: 10.2460/ajvr.68.3.290pubmed: 17331019google scholar: lookup
  8. Baselga García-Escudero J, Miguel Hernández Trillos P. Treatment of Osteoarthritis of the Knee with a Combination of Autologous Conditioned Serum and Physiotherapy: A Two-Year Observational Study.. PLoS One 2015;10(12):e0145551.
  9. Kon E, Mandelbaum B, Buda R, Filardo G, Delcogliano M, Timoncini A, Fornasari PM, Giannini S, Marcacci M. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis.. Arthroscopy 2011 Nov;27(11):1490-501.
    doi: 10.1016/j.arthro.2011.05.011pubmed: 21831567google scholar: lookup
  10. Tyrnenopoulou P, Diakakis N, Karayannopoulou M, Savvas I, Koliakos G. Evaluation of intra-articular injection of autologous platelet lysate (PL) in horses with osteoarthritis of the distal interphalangeal joint.. Vet Q 2016 Jun;36(2):56-62.
    doi: 10.1080/01652176.2016.1141257pubmed: 26828234google scholar: lookup
  11. Nixon AJ, Lust G, Vernier-Singer M. Isolation, propagation, and cryopreservation of equine articular chondrocytes.. Am J Vet Res 1992 Dec;53(12):2364-70.
    pubmed: 1476323
  12. Hix J, Klaassen M, Foreman R, Cullen E, Toler K, King W, Woodell-May J. An Autologous Anti-Inflammatory Protein Solution Yielded a Favorable Safety Profile and Significant Pain Relief in an Open-Label Pilot Study of Patients with Osteoarthritis.. Biores Open Access 2017;6(1):151-158.
    doi: 10.1089/biores.2017.0027pmc: PMC5738995pubmed: 29279807google scholar: lookup
  13. van Drumpt RA, van der Weegen W, King W, Toler K, Macenski MM. Safety and Treatment Effectiveness of a Single Autologous Protein Solution Injection in Patients with Knee Osteoarthritis.. Biores Open Access 2016;5(1):261-8.
    doi: 10.1089/biores.2016.0014pmc: PMC5031090pubmed: 27668131google scholar: lookup
  14. Wanstrath AW, Hettlich BF, Su L, Smith A, Zekas LJ, Allen MJ, Bertone AL. Evaluation of a Single Intra-Articular Injection of Autologous Protein Solution for Treatment of Osteoarthritis in a Canine Population.. Vet Surg 2016 Aug;45(6):764-74.
    doi: 10.1111/vsu.12512pubmed: 27391909google scholar: lookup
  15. Bertone AL, Ishihara A, Zekas LJ, Wellman ML, Lewis KB, Schwarze RA, Barnaba AR, Schmall ML, Kanter PM, Genovese RL. Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in horses.. Am J Vet Res 2014 Feb;75(2):141-51.
    doi: 10.2460/ajvr.75.2.141pubmed: 24471750google scholar: lookup
  16. Granowitz EV, Clark BD, Mancilla J, Dinarello CA. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor.. J Biol Chem 1991 Aug 5;266(22):14147-50.
    pubmed: 1830582
  17. Arend WP. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.. J Clin Invest 1991 Nov;88(5):1445-51.
    doi: 10.1172/JCI115453pmc: PMC295645pubmed: 1834696google scholar: lookup
  18. King W, van der Weegen W, Van Drumpt R, Soons H, Toler K, Woodell-May J. White blood cell concentration correlates with increased concentrations of IL-1ra and improvement in WOMAC pain scores in an open-label safety study of autologous protein solution.. J Exp Orthop 2016 Dec;3(1):9.
    doi: 10.1186/s40634-016-0043-7pmc: PMC4747972pubmed: 26915009google scholar: lookup
  19. Hraha TH, Doremus KM, McIlwraith CW, Frisbie DD. Autologous conditioned serum: the comparative cytokine profiles of two commercial methods (IRAP and IRAP II) using equine blood.. Equine Vet J 2011 Sep;43(5):516-21.
  20. Woodell-May J, Matuska A, Oyster M, Welch Z, O'Shaughnessey K, Hoeppner J. Autologous protein solution inhibits MMP-13 production by IL-1β and TNFα-stimulated human articular chondrocytes.. J Orthop Res 2011 Sep;29(9):1320-6.
    doi: 10.1002/jor.21384pubmed: 21437966google scholar: lookup
  21. Nielsen MK, Loynachan AT, Jacobsen S, Stewart JC, Reinemeyer CR, Horohov DW. Local and systemic inflammatory and immunologic reactions to cyathostomin larvicidal therapy in horses.. Vet Immunol Immunopathol 2015 Dec 15;168(3-4):203-10.
    doi: 10.1016/j.vetimm.2015.09.009pubmed: 26429413google scholar: lookup
  22. Finnson KW, Chi Y, Bou-Gharios G, Leask A, Philip A. TGF-b signaling in cartilage homeostasis and osteoarthritis.. Front Biosci (Schol Ed) 2012 Jan 1;4:251-68.
    doi: 10.2741/s266pubmed: 22202058google scholar: lookup
  23. Desancé M, Contentin R, Bertoni L, Gomez-Leduc T, Branly T, Jacquet S, Betsch JM, Batho A, Legendre F, Audigié F, Galéra P, Demoor M. Chondrogenic Differentiation of Defined Equine Mesenchymal Stem Cells Derived from Umbilical Cord Blood for Use in Cartilage Repair Therapy.. Int J Mol Sci 2018 Feb 10;19(2).
    doi: 10.3390/ijms19020537pmc: PMC5855759pubmed: 29439436google scholar: lookup
  24. Kisiday JD, Kopesky PW, Evans CH, Grodzinsky AJ, McIlwraith CW, Frisbie DD. Evaluation of adult equine bone marrow- and adipose-derived progenitor cell chondrogenesis in hydrogel cultures.. J Orthop Res 2008 Mar;26(3):322-31.
    doi: 10.1002/jor.20508pubmed: 17960654google scholar: lookup
  25. Ongchai S, Somnoo O, Kongdang P, Peansukmanee S, Tangyuenyong S. TGF-β1 upregulates the expression of hyaluronan synthase 2 and hyaluronan synthesis in culture models of equine articular chondrocytes.. J Vet Sci 2018 Nov 30;19(6):735-743.
    doi: 10.4142/jvs.2018.19.6.735pmc: PMC6265591pubmed: 30041292google scholar: lookup
  26. Blaney Davidson EN, Vitters EL, van den Berg WB, van der Kraan PM. TGF beta-induced cartilage repair is maintained but fibrosis is blocked in the presence of Smad7.. Arthritis Res Ther 2006;8(3):R65.
    doi: 10.1186/ar1931pmc: PMC1526625pubmed: 16584530google scholar: lookup
  27. Bakker AC, van de Loo FA, van Beuningen HM, Sime P, van Lent PL, van der Kraan PM, Richards CD, van den Berg WB. Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation.. Osteoarthritis Cartilage 2001 Feb;9(2):128-36.
    doi: 10.1053/joca.2000.0368pubmed: 11237660google scholar: lookup
  28. Rutgers M, Saris DB, Dhert WJ, Creemers LB. Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection.. Arthritis Res Ther 2010;12(3):R114.
    doi: 10.1186/ar3192pmc: PMC2911907pubmed: 20537160google scholar: lookup
  29. Jenkins JK, Arend WP. Interleukin 1 receptor antagonist production in human monocytes is induced by IL-1 alpha, IL-3, IL-4 and GM-CSF.. Cytokine 1993 Sep;5(5):407-15.
    doi: 10.1016/1043-4666(93)90030-9pubmed: 8142595google scholar: lookup
  30. Wojdasiewicz P, Poniatowski ŁA, Szukiewicz D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.. Mediators Inflamm 2014;2014:561459.
    doi: 10.1155/2014/561459pmc: PMC4021678pubmed: 24876674google scholar: lookup
  31. Kaneko S, Satoh T, Chiba J, Ju C, Inoue K, Kagawa J. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis.. Cytokines Cell Mol Ther 2000 Jun;6(2):71-9.
    doi: 10.1080/13684730050515796pubmed: 11108572google scholar: lookup
  32. Bertuglia A, Pagliara E, Grego E, Ricci A, Brkljaca-Bottegaro N. Pro-inflammatory cytokines and structural biomarkers are effective to categorize osteoarthritis phenotype and progression in Standardbred racehorses over five years of racing career.. BMC Vet Res 2016 Nov 8;12(1):246.
    doi: 10.1186/s12917-016-0873-7pmc: PMC5100096pubmed: 27821120google scholar: lookup
  33. de Hooge AS, van de Loo FA, Bennink MB, Arntz OJ, de Hooge P, van den Berg WB. Male IL-6 gene knock out mice developed more advanced osteoarthritis upon aging.. Osteoarthritis Cartilage 2005 Jan;13(1):66-73.
    doi: 10.1016/j.joca.2004.09.011pubmed: 15639639google scholar: lookup
  34. Svala E, Thorfve AI, Ley C, Henriksson HK, Synnergren JM, Lindahl AH, Ekman S, Skiöldebrand ES. Effects of interleukin-6 and interleukin-1β on expression of growth differentiation factor-5 and Wnt signaling pathway genes in equine chondrocytes.. Am J Vet Res 2014 Feb;75(2):132-40.
    doi: 10.2460/ajvr.75.2.132pubmed: 24471749google scholar: lookup
  35. Ley C, Svala E, Nilton A, Lindahl A, Eloranta ML, Ekman S, Skiöldebrand E. Effects of high mobility group box protein-1, interleukin-1β, and interleukin-6 on cartilage matrix metabolism in three-dimensional equine chondrocyte cultures.. Connect Tissue Res 2011;52(4):290-300.
    doi: 10.3109/03008207.2010.523803pubmed: 21117899google scholar: lookup
  36. Little CB, Flannery CR, Hughes CE, Mort JS, Roughley PJ, Dent C, Caterson B. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.. Biochem J 1999 Nov 15;344 Pt 1(Pt 1):61-8.
    doi: 10.1042/0264-6021:3440061pmc: PMC1220614pubmed: 10548534google scholar: lookup
  37. O'Shaughnessey K, Matuska A, Hoeppner J, Farr J, Klaassen M, Kaeding C, Lattermann C, King W, Woodell-May J. Autologous protein solution prepared from the blood of osteoarthritic patients contains an enhanced profile of anti-inflammatory cytokines and anabolic growth factors.. J Orthop Res 2014 Oct;32(10):1349-55.
    doi: 10.1002/jor.22671pmc: PMC4134723pubmed: 24981198google scholar: lookup

Citations

This article has been cited 22 times.
  1. Pezzanite LM, Chow L, Griffenhagen GM, Bass L, Goodrich LR, Impastato R, Dow S. Distinct differences in immunological properties of equine orthobiologics revealed by functional and transcriptomic analysis using an activated macrophage readout system. Front Vet Sci 2023;10:1109473.
    doi: 10.3389/fvets.2023.1109473pubmed: 36876001google scholar: lookup
  2. Toner S, Crosby C. Pro-stride and extracorporeal shockwave therapy as treatment of lateral collateral desmopathy of the proximal interphalangeal joint in a Dutch Warmblood gelding. Can Vet J 2023 Mar;64(3):268-274.
    pubmed: 36874545
  3. Löfgren M, Ekman S, Ekholm J, Engström M, Fjordbakk CT, Svala E, Holm Forsström K, Lindahl A, Skiöldebrand E. Conditioned serum in vitro treatment of chondrocyte pellets and osteoarthritic explants. Equine Vet J 2023 Mar;55(2):325-335.
    doi: 10.1111/evj.13582pubmed: 35514185google scholar: lookup
  4. Arévalo-Turrubiarte M, Baratta M, Ponti G, Chiaradia E, Martignani E. Extracellular vesicles from equine mesenchymal stem cells decrease inflammation markers in chondrocytes in vitro. Equine Vet J 2022 Nov;54(6):1133-1143.
    doi: 10.1111/evj.13537pubmed: 34741769google scholar: lookup
  5. Gaesser AM, Underwood C, Linardi RL, Even KM, Reef VB, Shetye SS, Mauck RL, King WJ, Engiles JB, Ortved KF. Evaluation of Autologous Protein Solution Injection for Treatment of Superficial Digital Flexor Tendonitis in an Equine Model. Front Vet Sci 2021;8:697551.
    doi: 10.3389/fvets.2021.697551pubmed: 34291103google scholar: lookup
  6. Camargo Garbin L, Morris MJ. A Comparative Review of Autologous Conditioned Serum and Autologous Protein Solution for Treatment of Osteoarthritis in Horses. Front Vet Sci 2021;8:602978.
    doi: 10.3389/fvets.2021.602978pubmed: 33681323google scholar: lookup
  7. Pagani S, Veronesi F, Giavaresi G, Filardo G, Papio T, Romandini I, Fini M. Autologous Protein Solution Effect on Chondrogenic Differentiation of Mesenchymal Stem Cells from Adipose Tissue and Bone Marrow in an Osteoarthritic Environment. Cartilage 2021 Dec;13(2_suppl):225S-237S.
    doi: 10.1177/1947603521993217pubmed: 33583216google scholar: lookup
  8. Velloso Alvarez A, Boone LH, Braim AP, Taintor JS, Caldwell F, Wright JC, Wooldridge AA. A Survey of Clinical Usage of Non-steroidal Intra-Articular Therapeutics by Equine Practitioners. Front Vet Sci 2020;7:579967.
    doi: 10.3389/fvets.2020.579967pubmed: 33195592google scholar: lookup
  9. Velloso Alvarez A, Boone LH, Pondugula SR, Caldwell F, Wooldridge AA. Effects of Autologous Conditioned Serum, Autologous Protein Solution, and Triamcinolone on Inflammatory and Catabolic Gene Expression in Equine Cartilage and Synovial Explants Treated With IL-1β in Co-culture. Front Vet Sci 2020;7:323.
    doi: 10.3389/fvets.2020.00323pubmed: 32671108google scholar: lookup
  10. Angadi DS, Macdonald H, Atwal N. Autologous cell-free serum preparations in the management of knee osteoarthritis: what is the current clinical evidence?. Knee Surg Relat Res 2020 Mar 23;32(1):16.
    doi: 10.1186/s43019-020-00036-5pubmed: 32660628google scholar: lookup
  11. Bertone AL, Reinemeyer C, Tsaprailis G, Ragland D, Leise B. Cryopreserved equine umbilical cord tissue allograft characterization and biocompatibility in vivo in musculoskeletal tissues: a controlled study. BMC Med 2025 Jul 23;23(1):439.
    doi: 10.1186/s12916-025-04231-7pubmed: 40702469google scholar: lookup
  12. Roth SP, Liso G, Brehm W, Wagner B, Schnabel CL, Troillet A. Selected cytokine and chemokine concentrations in equine autologous conditioned serum are similar under defined and practically relevant storage conditions. Front Vet Sci 2025;12:1588240.
    doi: 10.3389/fvets.2025.1588240pubmed: 40496923google scholar: lookup
  13. Najeb M, Samy A, Rizk A, Mosbah E, Karrouf G. Clinical benefits of early-stage autologous conditioned serum and injectable platelet-rich fibrin on healing superficial digital flexor tendonitis in donkeys. Ir Vet J 2025 Jun 7;78(1):13.
    doi: 10.1186/s13620-025-00299-ypubmed: 40483508google scholar: lookup
  14. Guerra-Gomes M, Ferreira-Baptista C, Barros J, Alves-Pimenta S, Gomes P, Colaço B. Exploring the Potential of Non-Cellular Orthobiologic Products in Regenerative Therapies for Stifle Joint Diseases in Companion Animals. Animals (Basel) 2025 Feb 18;15(4).
    doi: 10.3390/ani15040589pubmed: 40003071google scholar: lookup
  15. Elkhenany HA, Linardi RL, Ortved KF. Differential modulation of inflammatory cytokines by recombinant IL-10 in IL-1β and TNF-α ̶ stimulated equine chondrocytes and synoviocytes: impact of washing and timing on cytokine responses. BMC Vet Res 2024 Dec 2;20(1):546.
    doi: 10.1186/s12917-024-04403-2pubmed: 39623412google scholar: lookup
  16. Usimaki A, Ciamillo SA, Barot D, Linardi RL, Engiles JB, Ortved KF. Single injection of intra-articular autologous protein solution in horses with acute interleukin-1B-induced synovitis decreases joint pathology scores. Equine Vet J 2025 May;57(3):806-816.
    doi: 10.1111/evj.14203pubmed: 39051479google scholar: lookup
  17. Reis IL, Lopes B, Sousa P, Sousa AC, Rêma A, Caseiro AR, Briote I, Rocha AM, Pereira JP, Mendonça CM, Santos JM, Lamas L, Atayde LM, Alvites RD, Maurício AC. Case report: Equine metacarpophalangeal joint partial and full thickness defects treated with allogenic equine synovial membrane mesenchymal stem/stromal cell combined with umbilical cord mesenchymal stem/stromal cell conditioned medium. Front Vet Sci 2024;11:1403174.
    doi: 10.3389/fvets.2024.1403174pubmed: 38840629google scholar: lookup
  18. Reis IL, Lopes B, Sousa P, Sousa AC, Caseiro AR, Mendonça CM, Santos JM, Atayde LM, Alvites RD, Maurício AC. Equine Musculoskeletal Pathologies: Clinical Approaches and Therapeutical Perspectives-A Review. Vet Sci 2024 Apr 26;11(5).
    doi: 10.3390/vetsci11050190pubmed: 38787162google scholar: lookup
  19. Connard SS, Gaesser AM, Clarke EJ, Linardi RL, Even KM, Engiles JB, Koch DW, Peffers MJ, Ortved KF. Plasma and synovial fluid extracellular vesicles display altered microRNA profiles in horses with naturally occurring post-traumatic osteoarthritis: an exploratory study. J Am Vet Med Assoc 2024 Jun 1;262(S1):S83-S96.
    doi: 10.2460/javma.24.02.0102pubmed: 38593834google scholar: lookup
  20. Ortved KF, Alward L, Cowles B, Linardi R, Barot D, Usimaki A, Fedie JR, Amodie D, Goodrich LR. Use of quantitative mass spectrometry-based proteomics and ELISA to compare the alpha 2 macroglobulin concentration in equine blood-based products processed by three different orthobiologic devices. Front Vet Sci 2024;11:1335972.
    doi: 10.3389/fvets.2024.1335972pubmed: 38406632google scholar: lookup
  21. Della Tommasa S, Brehm W, Farì G, Bernetti A, Imperante A. Use of Autologous Conditioned Serum (ACS) for Osteoarthritis Treatment in Horses: A Systematic Review of Clinical Data. Vet Sci 2023 Dec 18;10(12).
    doi: 10.3390/vetsci10120707pubmed: 38133258google scholar: lookup
  22. Pérez Fraile A, González-Cubero E, Martínez-Flórez S, Olivera ER, Villar-Suárez V. Regenerative Medicine Applied to Musculoskeletal Diseases in Equines: A Systematic Review. Vet Sci 2023 Nov 23;10(12).
    doi: 10.3390/vetsci10120666pubmed: 38133217google scholar: lookup